Dublin-based biotech firm's Alzheimer's therapy fast-tracked by the FDA - IrishCentral

The Dublin-based Prothena Corporation announced that its Alzheimer's therapy PRX012 has received Fast Track status by the US Food and Drug Administration (FDA).

Prothena Corporation, a late-stage clinical biotechnology company based in Dublin and San Francisco, announced on April 26 that the US Food and Drug Administration (FDA) has granted Fast Track design… [+2973 chars]

full article...